Suggestions
Journal Information
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
Cite
Cite
Share
Download PDF
More article options
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
685
Full text access

PREVALENCE AND DETERMINANTS OF POST-COVID CONDITIONS IN A CITY IN SÃO PAULO STATE

Visits
532
Heloiza Thaís Felippe de Camargo da Silvaa,
Corresponding author
heloiza.thais@unesp.br

Corresponding author.
, Enya Julia Zucari Nogueiraa, José Eduardo Correntea, Carlos Magno Castelo Branco Fortalezaa, Lucas Frederico Arantesa, Lila Teixeira de Araujob, Camila Gonçalves Alvesa, Karen Ingrid Tascaa
a Faculdade de Medicina de Botucatu (FMB), Universidade Estadual Paulista (Unesp), Botucatu, SP, Brazil
b Universidade do Estado da Bahia (UNEB), Salvador, BA, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 30. Issue S1

XXIV Brazilian Congress of Infectious Diseases 2025

More info
Introduction

SARS-CoV-2 infection leads to prolonged repercussions, the Post-COVID Conditions (PCC), which represent a global health challenge. PCC prevalence varies, making it difficult to understand its true impact and risk factors. Understanding its magnitude and associated elements is crucial to support effective public policies.

Objective

To calculate the frequency of PCC in a city in the interior of São Paulo and identify associated risk factors, including demographic variables, clinical variables (acute COVID-19), pre-existing diseases, and vaccination status.

Method

Cross-sectional study with 3,088 individuals selected by randomization from approximately 50,000 mild, moderate, or severe COVID-19 cases notified in Botucatu, São Paulo, between January 2020 and May 2022. Secondary data were extracted from e-SUS Notifica and SIVEP-Gripe reports. Participants were contacted by telephone. Statistical analysis used chi-square test, independent t-test, and logistic regression (p < 0.05).

Results

Among those included, 697 (22.6%) reported PCC. Age and proportion of asymptomatic individuals in the acute phase were homogeneous between groups with and without PCC. In the PCC group, there was a higher proportion of women (62.7% vs 55.1%, p < 0.001), hospitalized individuals (8.2% vs 5.6%, p = 0.013), unvaccinated individuals (48.2% vs 43.6%), and those with pre-existing comorbidities (16.8% vs 12.6%, p = 0.005). Among these, there was a higher proportion of cardiovascular diseases (9.4% vs 6.4%, p = 0.008) and obesity (1.8% vs 0.7%, p = 0.015) in the PCC group. In the same group, acute-phase symptoms such as cough, fever, anosmia, and headache were more frequent (p < 0.05) than in the group without PCC. In multivariate analysis, female sex was a significant risk factor for PCC (OR = 1.441; 95% CI: 1.205–1.724), and a higher number of vaccine doses was a protective factor (OR = 0.871; 95% CI: 0.811–0.937). The presence of symptoms during the acute phase was associated with the outcome (OR = 0.913; 95% CI: 0.725–1.150).

Conclusion

PCC are a relevant problem in the interior of São Paulo, affecting more than one fifth of the population. Identifying female sex as a risk factor and complete vaccination as a protective factor highlights the importance of differentiated prevention and management strategies to mitigate the long-term impact of the pandemic.

Keywords:
Post-acute COVID-19 conditions
SARS-CoV-2
Risk factor
PDF
Full text is only available in PDF
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools